• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-12/白细胞介素-35通路的基因变体rs2243115会增加患冠状动脉疾病的风险。

Genetic variant rs2243115 of the IL-12/IL-35 pathway contributes to the risk of coronary artery disease.

作者信息

Chen Qianwen, Zhang Wenjuan, Xie Tian, Dong Jiangtao, Zhang Junxia, Zha Lingfeng

机构信息

Department of Pediatric Cardiology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430070, China.

Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

出版信息

Int J Med Sci. 2025 Apr 13;22(9):2155-2164. doi: 10.7150/ijms.102562. eCollection 2025.

DOI:10.7150/ijms.102562
PMID:40303485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12035836/
Abstract

Coronary artery disease (CAD) involves inflammation. IL-12p35, a common subunit of both IL-12 and IL-35, is encoded by the gene and is a potential therapeutic target in CAD. We probed into the genetic relationships between and CAD in a Chinese Han population to provide a novel potential target and a theoretical basis for the anti-inflammatory therapies in CAD. In total, 768 patients with CADs and 768 controls were recruited for a case-control association analysis of the functional genetic variant rs2243115 of . Allelic and genotypic associations between rs2243115 and CAD and its subgroup were assessed by Logistic regression analysis. Additionally, multiple linear regression analysis was performed to explore the association between rs2243115, serum lipid levels and CAD severity. Bioinformatic tools were used to predict the potential function of rs2243115. Our results showed no differences in the allele and genotype frequency distribution of rs2243115 between patients with CAD and controls. The subgroup analysis found no association between rs2243115 and CAD in either male or female groups. Furthermore, rs2243115 was not related to early- or late-onset CAD, or CAD severity. However, we did observe that rs2243115 was negatively related to HDL-c level (=0.016, 0.063) and positively related to LDL-c level (=0.029, =0.058). Biological function prediction indicated many functional elements in the rs2243115 region, suggesting that rs2243115 may regulate gene expression in the IL-12/IL-35 pathway. The functional genetic variant, rs2243115, of , may play a role in CAD by regulating the IL-12/IL-35 pathway and affecting lipid levels and inflammatory responses, thereby providing a potential therapeutic target for CAD.

摘要

冠状动脉疾病(CAD)涉及炎症。IL-12p35是IL-12和IL-35的共同亚基,由该基因编码,是CAD的一个潜在治疗靶点。我们在中国汉族人群中探究了该基因与CAD之间的遗传关系,为CAD的抗炎治疗提供新的潜在靶点和理论依据。总共招募了768例CAD患者和768例对照,对该基因的功能遗传变异rs2243115进行病例对照关联分析。通过逻辑回归分析评估rs2243115与CAD及其亚组之间的等位基因和基因型关联。此外,进行多元线性回归分析以探究rs2243115、血脂水平与CAD严重程度之间的关联。使用生物信息学工具预测rs2243115的潜在功能。我们的结果显示,CAD患者与对照之间rs2243115的等位基因和基因型频率分布没有差异。亚组分析发现,rs2243115在男性或女性组中与CAD均无关联。此外,rs2243115与早发或晚发CAD或CAD严重程度无关。然而,我们确实观察到rs2243115与高密度脂蛋白胆固醇(HDL-c)水平呈负相关(P = 0.016,β = -0.063),与低密度脂蛋白胆固醇(LDL-c)水平呈正相关(P = 0.029,β = 0.058)。生物学功能预测表明rs2243115区域存在许多功能元件,提示rs2243115可能调节IL-12/IL-35途径中的基因表达。该基因的功能遗传变异rs2243115可能通过调节IL-12/IL-35途径并影响血脂水平和炎症反应在CAD中发挥作用,从而为CAD提供一个潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26da/12035836/63ec57373e9a/ijmsv22p2155g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26da/12035836/a2a999fa14b7/ijmsv22p2155g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26da/12035836/c0a87b31a397/ijmsv22p2155g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26da/12035836/970188fd6949/ijmsv22p2155g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26da/12035836/e5445593a61f/ijmsv22p2155g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26da/12035836/63ec57373e9a/ijmsv22p2155g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26da/12035836/a2a999fa14b7/ijmsv22p2155g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26da/12035836/c0a87b31a397/ijmsv22p2155g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26da/12035836/970188fd6949/ijmsv22p2155g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26da/12035836/e5445593a61f/ijmsv22p2155g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26da/12035836/63ec57373e9a/ijmsv22p2155g005.jpg

相似文献

1
Genetic variant rs2243115 of the IL-12/IL-35 pathway contributes to the risk of coronary artery disease.白细胞介素-12/白细胞介素-35通路的基因变体rs2243115会增加患冠状动脉疾病的风险。
Int J Med Sci. 2025 Apr 13;22(9):2155-2164. doi: 10.7150/ijms.102562. eCollection 2025.
2
The Contribution of Interleukin-12A and Interleukin-12B Genotypes to Colorectal Cancer in Taiwan.白细胞介素-12A和白细胞介素-12B基因分型对台湾地区结直肠癌的影响
Anticancer Res. 2025 Apr;45(4):1501-1512. doi: 10.21873/anticanres.17532.
3
Association between interleukin-35 polymorphisms and coronary heart disease in the Chinese Zhuang population: a case-control study.中国壮族人群白细胞介素-35基因多态性与冠心病的关联:一项病例对照研究
Coron Artery Dis. 2018 Aug;29(5):423-428. doi: 10.1097/MCA.0000000000000635.
4
Analysis for interaction between interleukin-35 genes polymorphisms and risk factors on susceptibility to coronary heart disease in the Chinese Han population.白细胞介素-35 基因多态性与中国汉族人群冠心病易感性相关因素的交互作用分析。
BMC Cardiovasc Disord. 2021 Jan 6;21(1):6. doi: 10.1186/s12872-020-01811-8.
5
Genetic Analysis Reveals Different Mechanisms of IL-5 Involved in the Development of CAD in a Chinese Han Population.遗传分析揭示了白细胞介素-5(IL-5)在中国汉族人群中参与 CAD 发展的不同机制。
Oxid Med Cell Longev. 2023 Jan 31;2023:1700857. doi: 10.1155/2023/1700857. eCollection 2023.
6
The IL-33-ST2L pathway is associated with coronary artery disease in a Chinese Han population.IL-33-ST2L 通路与汉族人群的冠状动脉疾病相关。
Am J Hum Genet. 2013 Oct 3;93(4):652-60. doi: 10.1016/j.ajhg.2013.08.009. Epub 2013 Sep 26.
7
The Contribution of Interleukin-12A Genotypes to Oral Cancer Risk in Taiwanese.白细胞介素-12A 基因型对台湾人口腔癌风险的贡献。
Anticancer Res. 2020 Jul;40(7):3707-3712. doi: 10.21873/anticanres.14359.
8
Effects of IL-32 polymorphisms and IL-32 levels on the susceptibility and severity of coronary artery disease.白细胞介素 32 多态性和白细胞介素 32 水平对冠心病易感性和严重程度的影响。
J Clin Lab Anal. 2022 Jan;36(1):e24114. doi: 10.1002/jcla.24114. Epub 2021 Nov 19.
9
Lack of association between a common polymorphism of the endothelial lipase gene and early-onset coronary artery disease in a Chinese Han population.中国汉族人群中内皮脂肪酶基因常见多态性与早发冠状动脉疾病之间不存在关联。
Genet Mol Res. 2014 Feb 20;13(1):1059-69. doi: 10.4238/2014.February.20.7.
10
Analysis of the genetic association between IL27 variants and coronary artery disease in a Chinese Han population.中国汉族人群中IL27基因变异与冠状动脉疾病的遗传关联分析。
Sci Rep. 2016 May 12;6:25782. doi: 10.1038/srep25782.

本文引用的文献

1
Hegemony of inflammation in atherosclerosis and coronary artery disease.动脉粥样硬化和冠心病中的炎症霸权。
Eur J Pharmacol. 2024 Mar 5;966:176338. doi: 10.1016/j.ejphar.2024.176338. Epub 2024 Jan 17.
2
Global Burden of Cardiovascular Diseases and Risks, 1990-2022.1990 - 2022年心血管疾病及其风险的全球负担
J Am Coll Cardiol. 2023 Dec 19;82(25):2350-2473. doi: 10.1016/j.jacc.2023.11.007.
3
Gene Regulatory Networks in Coronary Artery Disease.冠状动脉疾病中的基因调控网络。
Curr Atheroscler Rep. 2023 Dec;25(12):1013-1023. doi: 10.1007/s11883-023-01170-7. Epub 2023 Nov 27.
4
The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived.慢性冠状动脉粥样硬化患者启动抗炎治疗的时机已经到来。
Circulation. 2023 Oct 3;148(14):1071-1073. doi: 10.1161/CIRCULATIONAHA.123.066510. Epub 2023 Oct 2.
5
LDL-C Reduction With Lipid-Lowering Therapy for Primary Prevention of Major Vascular Events Among Older Individuals.降脂治疗降低 LDL-C 以预防老年人主要血管事件
J Am Coll Cardiol. 2023 Oct 3;82(14):1381-1391. doi: 10.1016/j.jacc.2023.07.027.
6
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2023 年 AHA/ACC/ACCP/ASPC/NLA/PCNA 慢性冠状动脉疾病患者管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2023 Aug 29;82(9):833-955. doi: 10.1016/j.jacc.2023.04.003. Epub 2023 Jul 20.
7
Single-Cell Atlas of Atherosclerosis Patients by Cytof: Circulatory and Local Immune Disorders.单细胞图谱分析动脉粥样硬化患者的细胞因子:循环和局部免疫紊乱。
Aging Dis. 2024 Feb 1;15(1):245-258. doi: 10.14336/AD.2023.0426-1.
8
Atherosclerosis: The Involvement of Immunity, Cytokines and Cells in Pathogenesis, and Potential Novel Therapeutics.动脉粥样硬化:免疫、细胞因子和细胞在发病机制中的作用及潜在的新型治疗方法
Aging Dis. 2023 Aug 1;14(4):1214-1242. doi: 10.14336/AD.2022.1208.
9
Gene polymorphism in IL17A and gene-gene interaction in the IL23R/IL17A axis are associated with susceptibility to coronary artery disease.IL17A基因多态性以及IL23R/IL17A轴中的基因-基因相互作用与冠状动脉疾病易感性相关。
Cytokine. 2023 Apr;164:156142. doi: 10.1016/j.cyto.2023.156142. Epub 2023 Feb 18.
10
Interleukin-35 Mitigates ox-LDL-Induced Proatherogenic Effects via Modulating miRNAs Associated with Coronary Artery Disease (CAD).白细胞介素-35 通过调节与冠心病(CAD)相关的 miRNAs 减轻 ox-LDL 诱导的促动脉粥样硬化作用。
Cardiovasc Drugs Ther. 2023 Aug;37(4):667-682. doi: 10.1007/s10557-022-07335-x. Epub 2022 Apr 18.